As Gabasa et al. reported, there may be different mechanisms involved in TGF-β signaling, as well as aberrant CAF-carcinoma crosstalk in adenocarcinomas and squamous cell carcinomas28. This evidence concerns the gene TGFB1 and adenocarcinoma.